David Loesch

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

The Lancet · 2011 · 883 citations

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers

Journal of Clinical Oncology · 2010 · 524 citations